Riskpilot← Back to searchSign inGet full accessFridhemapotek AB
ABActiveOrg 5567922686Regementsgatan 94Retail sale of pharmaceutical products · NACE 4773Est. 20095-9 employees
Revenue 2024
SEK 22,2M
-8% vs 2023
EBITDA margin
-6.8%
-3156% vs 2023
Equity ratio
12.2%
Financial strength
Net profit 2024
SEK -1,6M
-47224% vs 2023
| Revenue | SEK 22,2M | -8% |
| EBITDA | SEK -1,5M | -3156% |
| Net profit | SEK -1,6M | -47224% |
| Total assets | SEK 4,9M | -22% |
| Equity | SEK 598K | -72% |
| Employees | — | — |
Legal name
Fridhemapotek AB
Org number
5567922686
Legal form
Aktiebolag
NACE code
4773 · Retail sale of pharmaceutical products
Founded
2 november 2009
Share capital
SEK 100 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av Emam, Parviz Emam, Setareh Jennifer
Company purpose
Bolaget skall bedriva detaljhandel med läkemedel, dvs försäljning av läkemedel samt hygienvaror och hälsokostvaror till konsument samt därmed förenlig verksamhet.
Address
Regementsgatan 94
Phone
+46708169010
Email
parviz@regementsapotek.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 16 370 | 15 945 | 20 921 | 21 080 | 22 840 | 24 157 | 22 238 |
| Staff expenses | — | — | — | — | — | — | — | — | −3 407 | — |
| EBITDA | 287 | 640 | 405 | −1 060 | 415 | 136 | 459 | 642 | 49 | −1 509 |
| Depreciation & amort. | −114 | −58 | −42 | −43 | −26 | −26 | −28 | −34 | −32 | −37 |
| EBIT | 173 | 582 | 363 | −1 103 | 389 | 110 | 431 | 608 | 18 | −1 546 |
| Net financials | −24 | −1 | −1 | −15 | −23 | −6 | −1 | −1 | −8 | −27 |
| Profit before tax | 120 | 482 | 272 | −778 | 366 | 103 | 430 | 606 | 10 | −1 574 |
| Tax | −28 | −108 | −65 | −0 | −0 | −0 | −42 | −130 | −13 | −0 |
| Net profit | 92 | 374 | 207 | −778 | 366 | 103 | 388 | 476 | −3 | −1 574 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 3 907 | 4 521 | 4 561 | 4 624 | 4 317 | 4 997 | 5 049 | 5 395 | 6 309 | 4 899 |
| Equity | 1 662 | 2 036 | 2 242 | 1 465 | 1 831 | 1 934 | 1 972 | 2 448 | 2 172 | 598 |
| Long-term debt | 174 | 174 | 94 | 575 | 754 | 821 | 393 | 376 | 900 | 1 196 |
| Short-term debt | 1 921 | 2 061 | 1 884 | 2 585 | 1 732 | 2 241 | 2 684 | 2 571 | 3 238 | 3 105 |
| Total debt | 2 095 | 2 235 | 1 978 | 3 160 | 2 486 | 3 062 | 3 077 | 2 947 | 4 137 | 4 301 |
EBITDA margin
-6.8%
This company
15.8%
Market median
-143% vs market
20152024
Equity ratio
12.2%
This company
38.2%
Market median
-68% vs market
20152024
Return on equity
-263.2%
This company
18.4%
Market median
-1530% vs market
20152024
Net profit margin
-7.1%
This company
8.1%
Market median
-188% vs market
20152024
Asset turnover
4.54×
This company
1.12×
Market median
+305% vs market
20152024
Debt / equity
7.19×
This company
0.62×
Market median
-1060% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SJ Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
EM Chief Auditor | Chief Auditor | 2023 | — | — |
MA | Audit | 2024 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fridhemapotek AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Setareh Jennifer Emam | Chief Executive Officer | 0 companies |
| Elvedin Music | Chief Auditor | 0 companies |
| Mats Anders Gyllenberg | Audit | 0 companies |
| Kobra Mona Fata | Board of Directors | 0 companies |
| Siamak Emam | Board of Directors | 0 companies |
| Parviz Emam | Chairman | 0 companies |